2
Important Safety Information
The ReliOn Platinum System
The ReliOn Platinum Blood Glucose
Monitoring System is comprised of the
ReliOn Platinum meter and ReliOn
Platinum test strips.
The ReliOn Platinum Blood Glucose
Monitoring System is intended to
quantitatively measure glucose in fresh
capillary whole blood from the fingertip as
an aid in monitoring the eectiveness of
glucose control.
The ReliOn Platinum Blood Glucose
Monitoring System is intended for in vitro
diagnostic single patient use by people
with diabetes at home.
The ReliOn Platinum Blood Glucose
Monitoring System is intended to be used
by a single person and should not be
shared.
This system is not for use in diagnosis or
screening of diabetes mellitus, nor for
neonatal use.
ReliOn Platinum control solutions are for
use with the ReliOn Platinum Blood
Glucose Monitoring System to check that
the meters and test strips are working
together properly and that the test is
performing correctly.
The system includes:
ReliOn Platinum meter with batteries,
ReliOn Platinum test strips*, and control
solutions*.
Alternative Site Testing
Limitations
The ReliOn Platinum Blood Glucose
Monitoring System is not indicated for
Alternative Site Testing (AST).
*Some items may not be included in the
kit. They are a separate purchase.
WARNING
• Choking hazard. Small
parts. Keep away from
children under the age
of 3 years.
• Keep new and used batteries away
from children. Ingestion or insertion
into the body may cause chemical
burns, perforation of soft tissues, and
death. Severe burns may occur
within 2 hours of swallowing. If you
think a battery might have been
swallowed or placed inside any part
of the body, seek medical attention
immediately.
• If the battery compartment does not
close securely, stop using the
product and keep it away from
children. Contact Customer Service
at 1-800-819-1097.
NOTE
• The term “blood glucose” is used
when referring to blood sugar.
• Sample data screens are shown
throughout the manual. Your data will
dier.
Limitations
• Do not use the meter at high hematocrit
levels above 65 % or low hematocrit
levels below 10 %.
• Not for use in diagnosis or screening of
diabetes mellitus.
• Not for neonatal use.
83561_09410155001A EN ReliON.indd 283561_09410155001A EN ReliON.indd 2 3/23/2022 11:23:35 AM3/23/2022 11:23:35 AM